Department of Diabetes, Endocrinology & Metabolism City of Hope

Physician Scientist Diabetes, Endocrinology & Metabolism

City of Hope Comprehensive Cancer Center in Duarte, California, is accepting applications from qualified physician scientists for faculty positions as Associate/Full Professor. We are seeking a candidate with a strong background in basic, translational, or clinical research in thyroid cancer or metabolism. Priority will be given to those candidates with a track record of extramural funding.

Job Description

• The Department of Diabetes, Endocrinology, and Metabolism (DEM) at City of Hope provides care and conducts research on a variety of diabetes and endocrine disorders, including but not limited to: diabetes, obesity, thyroid cancer, endocrine tumors, metabolic bone diseases, reproductive disorders, and management of endocrine complications that can result from cancer treatment.
• The Department of DEM manages approximately 4,500 individual patients annually, including 7,500 outpatient visits and 6,500 inpatient visits.
• The Department has eleven faculty and hosts an ACGME-accredited endocrine subspecialty training program.
• The Bechman Research Institute and Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope have infrastructure to advance basic and translational research in cancer and diabetes.

Requirements

• Candidates must have a strong background in basic, translational, or clinical research in thyroid cancer or metabolism.
• A track record of extramural funding is preferred.

Benefits

• Total compensation: $300K - $450K (base pay commensurate with qualified academic rank). Additional incentives available.
• Excellent benefits package, including a generous retirement contribution plan.
• Eligible for Public Student Loan Forgiveness (PSLF) Program.
• Relocation may be available.

Community Overview

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope's uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope's growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago, and Phoenix areas.